# 89bio, Inc. (ETNB) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/ETNB
## Company Profile
- Ticker: ETNB
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Cardio-Metabolic
## Stock Data
- Close: Not available
- Market cap: Not available
## Business Overview
89bio is a liver and metabolic disease company focused on MASH and related liver biology. Its story is driven by the possibility of creating a major liver-disease franchise.
## Why The Stock Is Moving

Current closing-price context is not available for ETNB.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, 89bio sits in specialty biopharma.

## Business Model

The business depends on clinical data, dose strategy, and whether the company can deliver a differentiated MASH profile.

## Landscape Position

89bio is one of the more closely watched liver-disease names because efficacy and safety can quickly change the story.

## Future Catalysts

- 89bio's catalysts are pegozafermin in MASH and severe hypertriglyceridemia, where the next data step can materially change the valuation. The company is still being judged on metabolic-disease execution.

## Recent News
- 2025-09-18 05:02 EST — [89bio, Inc. Announces Agreement to be Acquired by Roche](https://biopharmsignal.com/news/ETNB/89bio-inc-announces-agreement-to-be-acquired-by-roche) — Source: 89bio, Inc.
- 2025-09-05 20:05 EST — [89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ETNB/89bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: 89bio, Inc.
- 2025-08-28 20:05 EST — [89bio to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ETNB/89bio-to-participate-in-upcoming-investor-conferences) — Source: 89bio, Inc.
- 2025-08-07 20:06 EST — [89bio Reports Second Quarter 2025 Financial Results and Corporate Updates](https://biopharmsignal.com/news/ETNB/89bio-reports-second-quarter-2025-financial-results-and-corporate-updates) — Source: 89bio, Inc.
- 2025-06-04 20:05 EST — [89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference](https://biopharmsignal.com/news/ETNB/89bio-to-participate-in-goldman-sachs-46th-annual-global-healthcare-conference) — Source: 89bio, Inc.